UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

February 20, 2002

(Date of Report)

NEORX CORPORATION

(Exact Name of Registrant as Specified in Charter)

Washington	0-16614	91-1261311
(State or Other Jurisdiction of Incorporation)	(Commission File No.)	(IRS Employer Identification No.)

410 West Harrison Street, Seattle, Washington 98119-4007
(Address of principal executive offices)                             (Zip Code)

(206) 281-7001

(Registrant’s telephone number, including area code)

TABLE OF CONTENTS

	Item 5. Other Events
	Item 7. Exhibits
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1

Item 5. Other Events

NEORX UPDATES STATUS OF TARGETED THERAPEUTIC

PRODUCT DEVELOPMENT PROGRAMS

     See Exhibit 99.1 for additional information.

Item 7. Exhibits

99.1 Press release dated February 20, 2002

     SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NEORX CORPORATION
Dated: February 28, 2002	By	/s/ RICHARD L. ANDERSON
		Richard L. Anderson Senior V-P, CFO and Secretary

EXHIBIT INDEX

Exhibit No.
99.1	Press Release dated February 20, 2002